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The synthesis procedures of the cationic lipid Diosarg:
Step 1: In a 100-mL flask were added diosgenin (414 mg, 1.0 mmol), Boc-N-caproic acid (231 mg, 1.5 mmol) and N,N'-dicyclohexylcarbodiimide (DCC)/4-Dimethylaminopyridine (DMAP) (300 mg/100 mg) dissolved in 50 mL of dichloromethane, and the mixture was stirred at ambient temperature for 24 h. Then, the dicyclohexylurea (DCU) solids were removed by filtration; the residual solution was further concentrated and then purified by flash column chromatography (EtOAC/hexane = 1/3 v/v) to achieve Dios-1 as a white solid (isolated yield: 66.1%).
Step 2: In a 50-mL flask, the Dios-1 (320 mg, 0.5 mmol) was dissolved in the mixture solution of CH2Cl2/CF3COOH (20 mL/5 mL) and stirred at ambient temperature for 2 h. Then, the solvent was removed under reduced pressure, and then Boc-protected arginine Boc-Arg·HCl·H2O (250 mg, 0.75 mol), 1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide (EDC)/DMAP (300 mg/100 mg), which was dissolved in the mixture solution of CH2Cl2/triethylamine (50 mL/5 mL), were added; then, the mixture was stirred at ambient temperature for 24 h and then washed with distilled water (3 × 100 mL), then concentrated under reduced pressure and purified by flash column chromatography (eluent: EtOAC/MeOH = 10/1 v/v) to get the Boc-protected Diosarg lipid precursor as a yellowish solid. Finally, the Boc groups were removed in CH2Cl2/CF3COOH (5 mL/5 mL) after a 3-h reaction at room temperature, then the solvent was removed and precipitated with diethyl ether. The final product, cationic lipid Diosarg, was obtained as a white solid (isolated yield: 59.6%). 13 C NMR (d4-MeOD, 75 Hz): δ 172. 7, 168.4, 159.2, 157.3, 139.7, 119.1, 116.0, 108.7, 80.5, 73.9, 66.4, 65.8, 56.2, 52.2, 49.5, 41.5, 40.5, 40.1, 39.8, 39.2, 38.4, 36.8, 36.6, 34.8, 34.1, 32.0, 31.3, 31.1, 28.9, 28.7, 25.9, 25.0, 24.2, 19.6, 18.7, 17.5, 15 Figure S2 . Hydrodynamic average particle sizes of the Diosarg-1,2-dioleoyl-sn-glycero-3-phosphorethanolamine (DOPE) (2:1, 1:1, 1:2) NPs in distilled water at room temperature measured by the dynamic light scattering instrument. 
S3. Agarose-Gel pDNA Retardation Assay of the pDNA Binding Affinity for the Diosarg Lipid and Diosarg-DOPE NPs
Experimental procedures of the agarose-gel pDNA retardation assay: Before the assay, the cationic lipid samples (Diosarg and Diosarg-DOPE NPs) were preliminarily dissolved in pure water to prepare the solution with the total Diosarg concentration of 1.7 × 10 −3 M (same Diosarg concentration for all of the Diosarg and Diosarg-DOPE NPs); the Diosarg/pDNA and Diosarg-DOPE NPs/pDNA complexes were prepared by mixing pDNA (1 μg) with a predetermined amount of the cationic lipid sample stock solutions under a pre-set ± charge ratio in 50 μL PBS (0.01 M, pH = 7.4) buffer solution. After incubation at 37 °C for 20 min, the Diosarg/pDNA and Diosarg-DOPE NPs/pDNA complex solution were loaded onto a 1% agarose gel containing 0.5 μg/mL ethidium bromide dye (EB). Then, the gel electrophoresis was conducted in 1 × TAE running buffer under 100 mV for 30 minutes, and the pDNA migration bands were thus observed and recorded on a UVP benchtop 2UV transilluminator system. 
